Role of Folylpolygutamate Synthetase (FPGS) in Antifolate Chemotherapy; a Biochemical and Clinical Update

References

• Niemeyer, C. M., Hitchcock, B. S., and Sallan, S. E. (1985) Comparative analysis of treatment programs for childhood acute lymphoblastic leukemia. Seminars in Oncology, 12, 122–30.
   PubMed Web of Science ®Google Scholar
• Keyomarsi, K. and Moran, R. G. (1988) Mechanism of the cyto-toxic synergism of fluoropyrimidines and folinic acid in mouse leukemic cells. Journal of Biological Chemistry, 263, 14402–9.
   PubMed Web of Science ®Google Scholar
• Arbuck, S. G. (1989) Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer. [Review]. Cancer, 63, 1036–44.
   PubMed Web of Science ®Google Scholar
• Boffetta, P. and Kaldor, J. M. (1994) Secondary malignancies fol-lowing cancer chemotherapy. [Review]. Acta Oncologica, 33,591–8.
   PubMed Web of Science ®Google Scholar
• Ochs, J. and Mulhern, R. (1994) Long-term sequelae of therapy for childhood acute lymphoblastic leukaemia. [Review]. Baillieres Clinical Haematology, 7, 365–76.
   PubMed Web of Science ®Google Scholar
• Chabner, B. A., et al. (1985) Polyglutamation of methotrexate. Is methotrexate a prodrug?. [Review]. Journal of Clinical Investigation, 76, 907–12.
   PubMed Web of Science ®Google Scholar
• Baldwin, S. W., et al. (1991) Structural features of 5,10-dideaza-5,6,7,8-tetrahydrofolate that determine inhibition of mammalian glycinamide ribonucleotide formyltransferase. Biochemistry, 30, 1997–2006.
   PubMed Web of Science ®Google Scholar
• Jackman, A. L., et al. (1991) ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study. Cancer Research, 51, 5579–86.
   PubMed Web of Science ®Google Scholar
• Moran, R. G., Shih, C., Taylor, E. C., and Grindey, G. B. (1992) Are classical antifolates directed at thymidylate synthase and purine synthesis prodrugs? (Meeting abstract). Proc Seventh NCI-EORTC Symposium on New Drugs in Cancer Therapy, p. 91. Amsterdam: NCI-EPRTC.
   Google Scholar
• Schroder, H. (1986) Methotrexate phannacokinetics in age-frac-tionated erythrocytes. Cancer Chemotherapy & Pharmacology, 18, 203–7.
   PubMed Web of Science ®Google Scholar
• Barredo, J. and Moran, R. G. (1992) Determinants of antifolate cy-totoxicity: folylpolyglutamate synthetase activity during cellular proliferation and development. Molecular Pharmacology, 42, 687–94.
   PubMed Web of Science ®Google Scholar
• Schmiegelow, K., et al. (1995) Risk of relapse in childhood acute lymphoblastic leukemia is related to rbc methotrexate and mercap-topurine metabolites during maintenance chemotherapy. Journal of Clinical Oncology, 13, 345–351.
   PubMed Web of Science ®Google Scholar
• Freisheim, J. H., Price, E. M., and Ratnam, M. (1989) Folate coen-zyme and antifolate transport proteins in normal and neoplastic cells. Advances in Enzyme Regulation, 29, 13–26.
   PubMedGoogle Scholar
• Kamen, B. A., Wang, M. T., Streckfuss, A. J., Peryea, X., and Anderson, R. G. (1988) Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that re-cycles. Journal of Biological Chemistry, 263, 13602–9.
   PubMed Web of Science ®Google Scholar
• Kim, J. S., Lowe, K. E., and Shane, B. (1993) Regulation of folate and one-carbon metabolism in mammalian cells. IV. Role of folylpoly-gamma-glutamate synthetase in methotrexate metabolism and cytotoxicity. Journal of Biological Chemistry, 268, 21680–5.
   PubMed Web of Science ®Google Scholar
• Allegra, C. J. (1990) ANTIFOLATES. [Review]. Cancer Chemotherapy: Principles, and Practice. Chabner B and Collins J eds., Philadelphia, Lippincott, pp. 110–53. Philadelphia: JB Lippincott.
   Google Scholar
• Henderson, G. B. and Strauss, B. P. (1990) Characteristics of a novel transport system for folate compounds in wild-type and methotrex-ate-resistant L1210 cells. Cancer Research, 50, 1709–14.
   PubMed Web of Science ®Google Scholar
• McGuire, J. J., Hsieh, P., and Bertino, J. R. (1984) Enzymatic syn-thesis of polyglutamate derivatives of 7-hydroxymethotrexate. Biochemical Pharmacology, 33, 1355–61.
   PubMed Web of Science ®Google Scholar
• Bognar, A. L., Osborne, C., Shane, B., Singer, S. C., and Ferone, R. (1985) Folylpoly-gamma-glutamate synthetase-dihydrofolate syn-thetase. Cloning and high expression of the Escherichia coli folC gene and purification and properties of the gene product. Journal of Biological Chemistry, 260, 5625–30.
   PubMed Web of Science ®Google Scholar
• Bognar, A. L. and Shane, B. (1983) Purification and properties of Lactobacillus casei folylpoly-gamma-glutamate synthetase. Journal of Biological Chemistry, 258, 12574–81.
   PubMedGoogle Scholar
• Garrow, T. A., Admon, A., and Shane, B. (1992) Expression cloning of a human cDNA encoding folylpoly(gamma-glutamate) syn- thetase and determination of its primary structure. Proceedings of the National Academy of Sciences of the United States of America, 89,9151–5.
   PubMed Web of Science ®Google Scholar
• Shane, B. (1989) Folylpolyglutamate synthesis and role in the reg-ulation of one-carbon metabolism. [Review]. Vitamins & Hormones, 45, 263–335.
   PubMed Web of Science ®Google Scholar
• Moran, R. G. and Colman, P. D. (1984) Measurement of folylpolyg-lutamate synthetase in mammalian tissues. Analytical Biochemistry, 140,326–42.
   PubMed Web of Science ®Google Scholar
• McBumey, M. W. and Whitmore, G. F. (1974) Isolation and bio-chemical characterization of folate deficient mutants of Chinese hamster cells. Cell, 2, 173–82.
   PubMed Web of Science ®Google Scholar
• Barredo, J. and Moran, R. G. (1992) Determinants of antifolate cy-totoxicity: folylpolyglutamate synthetase activity during cellular proliferation and development. Molecular Pharmacology, 42, 687–94.
   PubMed Web of Science ®Google Scholar
• Barredo, J. and Moran, R. G. (1991) Folypolyglutamate synthetase (FPGS) activity during proliferation, differentiation and develop-ment (meeting abstract). Proc Annu Meet Am Assoc Cancer Res.
   Google Scholar
• Lenz, H. J., et al. (1993) A polymerase chain reaction (PCR) assay for folylpolyglutamate synthetase (FPGS) gene expression: marked variation in human leukemia blast samples (Meeting abstract). Proc Annu Meet Am Assoc Cancer Res.
   Google Scholar
• Li, W. W., et al. (1992) Mechanisms of natural resistance to an-tifolates in human soft tissue sarcomas. Cancer Research, 52, 1434–8.
   PubMed Web of Science ®Google Scholar
• Barredo, J. C., et al. (1993) In vivo changes of folylpolyglutamate synthetase (FPGS) activity in blasts from children with ALL after methotrexate (MTX) therapy (Meeting abstract). Proc Annu Meet Am Assoc Cancer Res.
   Google Scholar
• Fort, D. W., et al. (1993) Accumulation of 5-methyltetrahydrofolic acid and folylpolyglutamate synthetase expression by mitogen stim-ulated human lymphocytes. British Journal of Haematology, 84, 595–601.
   PubMed Web of Science ®Google Scholar
• Barredo, J. C., et al. (1994) Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia. Blood, 84, 564–9.
   PubMed Web of Science ®Google Scholar
• Li, W. W., Lin, J. T., Schweitzer, B., Brennan, M. F., and Benin°, J. R. (1990) Inherent resistance to methotrexate in human soft tis-sue sarcoma (HSTS) cell lines (meeting abstract). Proc Annu Meet Am Assoc Cancer Res.
   Google Scholar
• Lenz, H. J., et al. (1994) Quantitative analysis of folylpolyglutamate synthetase gene expression in tumor tissues by the polymerase chain reaction-marked variation of expression among leukemia patients. Oncology Research, 6, 329–335.
   PubMed Web of Science ®Google Scholar
• Goker, E., et al. (1993) Decreased polyglutamylation of methotrex-ate in acute lymphoblastic leukemia blasts in adults compared to children with this disease. Leukemia, 7, 1000–4.
   PubMed Web of Science ®Google Scholar
• Rosenblatt, D. S., et al. (1978) Prolonged inhibition of DNA syn-thesis associated with the accumulation of methotrexate polygluta-mates by cultured human cells. Molecular Pharmacology, 14, 1143–7.
   PubMed Web of Science ®Google Scholar
• Galivan, J. (1980) Evidence for the cytotoxic activity of polygluta-mate derivatives of methotrexate. Molecular Pharmacology, 17, 105–10.
   PubMed Web of Science ®Google Scholar
• Jolivet, J. and Chabner, B. A. (1983) Intracellular pharmacokinet-ics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihy-drofolate reductase. Journal of Clinical Investigation, 72,773–8.
   PubMed Web of Science ®Google Scholar
• Jackman, A. L., et al. (1991) Thymidylate synthase inhibitors: the in vitro activity of a series of heterocyclic benzoyl ring modified 2-desamino-2-methyl-N10-substituted-5,8-dideazafolates. [Review]. Advances in Enzyme Regulation, 31, 13–27.
   PubMedGoogle Scholar
• Benin°, J. R. (1993) Karnofsky memorial lecture. Ode to methotrex-ate. [Review]. Journal of Clinical Oncology, 11, 5–14.
   PubMedGoogle Scholar
• Whitehead, V. M,, Rosenblatt, D. S., Vuchich, M. J.. and Beaulieu, D. (1987) Methotrexate polyglutamate synthesis in lymphoblasts from children with acute lymphoblastic leukemia. Developmental Pharmacology & Therapeutics, 10, 443–8.
   PubMedGoogle Scholar
• Samuels, L. L., Feinberg, A., Moccio, D. M., Sirotnak, F. M., and Rosen, G. (1984) Detection by high-performance liquid chro-matography of methotrexate and its metabolites in tumor tissue from osteosarcoma patients treated with high-dose methotrexate/leucov-orin rescue. Biochemical Pharmacology, 33, 2711–4.
   PubMed Web of Science ®Google Scholar
• Winick, N. J., et al. (1987) Folate and methotrexate polyglutamate tissue levels in rhesus monkeys following chronic low-dose methotrexate. Cancer Drug Delivery, 4, 25–31.
   PubMedGoogle Scholar
• Allegra, C. J., et al. (1985) Enhanced inhibition of thymidylate syn-thase by methotrexate polyglutamates. Journal of Biological Chemistry, 260,9720–6.
   PubMed Web of Science ®Google Scholar
• Allegra, C. J., Drake, J. C., Jolivet, J., and Chabner, B. A. (1985) Inhibition of phosphoribosylaminoimidazolecarboxamide trans-formylase by methotrexate and dihydrofolic acid polyglutamates. Proceedings of the National Academy of Sciences of the United States of America, 82, 4881–5.
   PubMed Web of Science ®Google Scholar
• Masson, E., et al. (1995) Inhibition of de nova purine synthesis is related to long-chain methotrexate polyglutamate concentrations in lymphoblasts. Proc Annu Meet Am Assoc Cancer Res.
   Google Scholar
• Beardsley, G. P., Moroson, B. A., Taylor, E. C., and Moran, R. G. (1989) A new folate antimetabolite, 5,10-dideaza-5,6,7,8-tetrahy-drofolate is a potent inhibitor of de nova purine synthesis. Journal of Biological Chemistry, 264, 328–33.
   PubMed Web of Science ®Google Scholar
• Jackman, A. L., et al. (1991) Thymidylate synthase inhibitors: the in vitro activity of a series of heterocyclic benzoyl ring modified 2-desamino-2-methyl-N10-substituted-5,8-dideazafolates. [Review]. Advances in Enzyme Regulation, 31, 13–27.
   PubMedGoogle Scholar
• Lu, K., McGuire, J. J., and Rustum, Y. M. (1995) Characterization of a folylpolyglutamate synthesis deficient, ZD1694-resistant/methotrexate sensitive HCT-8 human ileocecal adenocar-cinoma subline (meeting abstract). Proc Annu Meet Am Assoc Cancer Res..
   Google Scholar
• Rosowsky, A., Forsch, R. A., and Moran, R. G. (1993) Optimization of folate analogues with an omithine side chain as folyl-polygluta-mate synthetase (FPGS) inhibitors (Meeting abstract). Proc Annu Meet Am Assoc Cancer Res..
   Google Scholar
• Rosowsky, A., et al. (1986) Methotrexate analogues. 26. Inhibition of dihydrofolate reductase and folylpolyglutamate synthetase ac-tivity and in vitro tumor cell growth by methotrexate and aminopterin analogues containing a basic amino acid side chain. Journal of Medicinal Chemistry, 29, 655–60.
   PubMed Web of Science ®Google Scholar
• Whitehead, V. M., etal. (1990) Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts at diagnosis of child-hood acute lymphoblastic leukemia: a pilot prognostic factor analy-sis. Blood, 76, 44–9.
   Google Scholar
• Synold, T. W., etal. (1994) Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. Journal of Clinical Investigation, 94, 1996–2001.
   Google Scholar
• Galpin, A. J., et al. (1994) Differences in folylpolyglutamate syn-thetase (FPGS) mRNA expression in B-lineage and T-lineage acute lymphoblastic leukemia (ALL) (Meeting abstract). Proc Annu Meet Am Soc Clin Oncol.
   Google Scholar
• McCloskey, D. E., et al. (1991) Decreased folylpolyglutamate syn-thetase activity as a mechanism of methotrexate resistance in CCRF-CEM human leukemia sublines. Journal of Biological Chemistry, 266, 6181–7.
   PubMed Web of Science ®Google Scholar
• Ciaiolo, C., et al. (1988) Enhancement of methotrexate cytotoxic-ity by modulation of proliferative activity in normal and neoplastic T lymphocytes and in a myeloid leukemia cell line. Tumori, 74, 537–42.
   PubMed Web of Science ®Google Scholar
• Rumberger, B. G., Barrueco, J. R., and Sirotnak, F. M. (1990) Differing specificities for 4-aminofolate analogues of folylpolyglu-tamyl synthetase from tumors and proliferative intestinal epithelium of the mouse with significance for selective antitumor action. Cancer Research, 50, 4639–43.
   PubMed Web of Science ®Google Scholar